The interplay of prolactin and the glucocorticoids in the regulation of β-cell gene expression, fatty acid oxidation, and glucose-stimulated insulin secretion: Implications for carbohydrate metabolism in pregnancy

Endocrinology

Volumn 149, Issue 11, 2008, Pages 5401-5414

  Arumugam, Ramamani ^a   Horowitz, Eric ^a   Lu, Danhong ^a   Collier, J Jason ^a   Ronnebaum, Sarah ^a   Fleenor, Don ^a   Freemark, Michael ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CARNITINE PALMITOYLTRANSFERASE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOSE; GLUCOSE TRANSPORTER 2; HYDROCORTISONE; INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROLACTIN; STAT5B PROTEIN; TRANSCRIPTION FACTOR FKHR; UNCOUPLING PROTEIN 2;

ANIMAL CELL; ARTICLE; CARBOHYDRATE METABOLISM; CONSENSUS SEQUENCE; CONTROLLED STUDY; ESTERIFICATION; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLUCOSE TOLERANCE; HORMONAL REGULATION; INSULIN RELEASE; INSULINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PREGNANCY; PRIORITY JOURNAL; PROLACTIN RELEASE; PROMOTER REGION; RAT;

ANIMALS; CARBOHYDRATE METABOLISM; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; DEXAMETHASONE; DRUG INTERACTIONS; FATTY ACIDS; FEMALE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; OXIDATION-REDUCTION; PREGNANCY; PROLACTIN; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RATS; STAT5 TRANSCRIPTION FACTOR;

EID: 54349124549     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0051     Document Type: Article

References (89)

1. Catalano PM, Huston L, Amini SB, Kalhan SC 1999 Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 180:903-916
2. Freemark M 2006 Regulation of maternal metabolism by pituitary and placental hormones: roles in fetal development and metabolic programming. Horm Res 65(Suppl 3):41-49
3. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE 2007 Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 30(Suppl 2):S112-S119
4. Di Cianni G, Seghieri G, Lencioni C, Cuccuru I, Anichini R, De Bellis A, Ghio A, Tesi F, Volpe L, Del Prato S 2007 Normal glucose tolerance and gestational diabetes mellitus: what is in between? Diabetes Care 30:1783-1788
5. Buchanan TA, Xiang AH 2005 Gestational diabetes mellitus. J Clin Invest 115:485-491
6. Sorenson RL, Brelje TC, Roth C 1993 Effects of steroid and lactogenic hormones on islets of Langerhans: a new hypothesis for the role of pregnancy steroids in the adaptation of islets to pregnancy. Endocrinology 133:2227-2234
7. Ryan EA, Enns L 1988 Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 67:341-347
8. Fleenor D, Oden J, Kelly PA, Mohan S, Alliouachene S, Pende M, Wentz S, Kerr J, Freemark M 2005 Roles of the lactogens and somatogens in perinatal and postnatal metabolism and growth: studies of a novel mouse model combining lactogen resistance and growth hormone deficiency. Endocrinology 146:103-112
9. Lacroix MC, Guibourdenche J, Frendo JL, Muller F, Evain-Brion D 2002 Human placental growth hormone - a review. Placenta 23(Suppl A):S87-S94
10. Barbour LA, Shao J, Qiao L, Leitner W, Anderson M, Friedman JE, Draznin B 2004 Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle. Endocrinology 145:1144-1150
11. Brǎniçsteanu DD, Mathieu C 2003 Progesterone in gestational diabetes mellitus: guilty or not guilty? Trends Endocrinol Metab 14:54-56
12. Mastorakos G, Ilias I 2003 Maternal and fetal hypothalamic- pituitary-adrenal axes during pregnancy and postpartum. Ann NY Acad Sci 997:136-149
13. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Hutson-Presley L, Friedman JE, Kalhan SC, Catalano PM 2002 TNF-α is a predictor of insulin resistance in human pregnancy. Diabetes 51:2207-2213
14. Altinova AE, Toruner F, Bozkurt N, Bukan, N, Karakoc A, Yetkin I, Ayvaz G, Cakir N, Arslan M 2007 Circulating concentrations of adiponectin and tumor necrosis factor-α in gestational diabetes mellitus. Gynecol Endocrinol 23:161-165
15. Lambillotte C, Gilon P, Henquin JC 1997 Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest 99:414-423
16. Ranta F, Avram D, Berchtold S, Dufer M, Drews G, Lang F, Ullrich S 2006 Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4. Diabetes 55:1380-1390
17. Ullrich S, Berchtold S, Ranta F, Seebohm G, Henke G, Lupescu A, Mack AF, Chao CM, Su J, Nitschke R, Alexander D, Friedrich B, Wuff P 2005 Serum-and glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid- induced inhibition of insulin secretion. Diabetes 54:1090-1099
18. Weinhaus AJ, Bhagroo NV, Brelje TC, Sorenson RL 2000 Dexamethasone counteracts the effect of prolactin on islet function: implications for islet regulation in late pregnancy. Endocrinology 141:1384-1393
19. Shao J, Qiao L, Friedman JE 2004 Prolactin, progesterone, and dexamethasone coordinately and adversely regulate glucokinase and cAMP/PDE cascades in MIN6 β-cells. Am J Physiol Endocrinol Metab 286:E304-E310
20. Saldeen J 2000 Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology 141:2003-2010
21. Collier JJ, Fueger PT, Hohmeier HE, Newgard CB 2006 Pro- and antiapoptotic proteins regulate apoptosis but do not protect against cytokine-mediated cytotoxicity in rat islets and β-cell lines. Diabetes 55:1398-1406
22. Brelje TC, Scharp DW, Lacy PE, Ogren L, Talamantes F, Robertson M, Friesen HG, Sorenson RL 1993 Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology 132:879-887
23. Handschin C, Spiegelman BM 2006 Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 27:728-735
24. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W 1999 Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J Clin Invest 103:1489-1498
25. Minnich A, Tian N, Byan L, Bilder G 2001 A potent PPARα agonist stimulates mitochondrial fatty acid β-oxidation in liver and skeletal muscle. Am J Physiol Endocrinol Metab 280:E270-E279
26. Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D 2007 Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor foxo1 in liver. Cell Metab 6:208-216
27. Kawamori D, Kaneto H, Nakatani Y, Matsuoka TA, Matsuhisa M, Hori M, Yamasaki Y 2006 The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J Biol Chem 281:1091-1098
28. Nakae J, Biggs 3rd WH, Kitamura T, Cavenee WK, Wright CV, Arden KC, Accili D 2002 Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 32:245-253
29. Okamoto H, Hribal ML, Lin HV, Bennett WR, Ward A, Accili D 2006 Role of the forkhead protein FoxO1 in β cell compensation to insulin resistance. J Clin Invest 116:775-782
30. Buteau J, Shlien A, Foisy S, Accili D 2007 Metabolic diapause in pancreatic β-cells expressing a gain-of-function mutant of the forkhead protein Foxo1. J Biol Chem 282:287-293
31. Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs 3rd WH, Wright CV, White MF, Arden KC, Accili D 2002 The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth. J Clin Invest 110:1839-1847
32. Yoon JC, Xu G, Deeney JT, Yang SN, Rhee J, Puigserver P, Levens AR, Yang R, Zhang CY, Lowell BB, Berggren PO, Newgard CB, Bonnie-Weir S, Weir G, Spiegelman BM 2003 Suppression of β cell energy metabolism and insulin release by PGC-1α. Dev Cell 5:73-83
33. Soyal S, Krempler F, Oberkofler H, Patsch W 2006 PGC-1α: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes. Diabetologia 49:1477-1488
34. Gremlich S, Nolan C, Roduit R, Burcelin R, Peyot ML, Delghingaro-Augusto V, Desvergne B, Michalik L, Prentki M, Wahli W 2005 Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor α transcriptional up-regulation of fatty acid oxidation. Endocrinology 146:375-382
35. Tordjman K, Standley KN, Bernal-Mizrachi C, Leone TC, Coleman T, Kell PA, Semenkovich CF 2002 PPARα suppresses insulin secretion and induces UCP2 in insulinoma cells. J Lipid Res 43:936-943
36. Oberkofler H, Klein K, Felder TK, Krempler F, Patsch W 2006 Role of peroxisome proliferator-activated receptor-γ coactivator-1α in the transcriptional regulation of the human uncoupling protein 2 gene in INS-1E cells. Endocrinology 147:966-976
37. Li LX, Skorpen F, Egeberg K, Jorgensen IH, Grill V 2002 Induction of uncoupling protein 2 mRNA in β-cells is stimulated by oxidation of fatty acids but not by nutrient oversupply. Endocrinology 143:1371-1377
38. Herrero L, Rubi B, Sebastian D, Serra D, Asins G, Maechler P, Prentki M, Hegardt FG 2005 Alteration of the malonyl-CoA/carnitine palmitoyltransferase I interaction in the β-cell impairs glucose-induced insulin secretion. Diabetes 54:462-471
39. Sadana P, Zhang Y, Song S, Cook GA, Elam MB, Park EA 2007 Regulation of carnitine palmitoyltransferase I (CPT-Iα) gene expression by the peroxisome proliferator activated receptor γ coactivator (PGC-1) isoforms. Mol Cell Endocrinol 267:6-16
40. Holness MJ, Smith ND, Greenwood GK, Sugden MC 2005 Interactive influences of peroxisome proliferator-activated receptor α activation and glucocorticoids on pancreatic β cell compensation in insulin resistance induced by dietary saturated fat in the rat. Diabetologia 48:2062-2068
41. Holness MJ, Greenwood GK, Smith ND, Sugden MC 2006 Peroxisome proliferator-activated receptor-α and glucocorticoids interactively regulate insulin secretion during pregnancy. Diabetes 55:3501-3508
42. Rubi B, Antinozzi PA, Herrero L, Ishihara H, Asins G, Serra D, Wollheim, CB, Maechler P, Hegardt FG 2002 Adenovirus-mediated overexpression of liver carnitine palmitoyltransferase I in INS1E cells: effects on cell metabolism and insulin secretion. Biochem J 364:219-226
43. Milburn Jr JL, Hirose H, Lee YH, Nagasawa Y, Ogawa A, Ohneda M, BeltrandelRio H, Newgard CB, Johnson JH, Unger RH 1995 Pancreatic β-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem 270:1295-1299
44. Friedrichsen BN, Richter HE, Hansen JA, Rhodes CJ, Nielsen JH, Billestrup N, Moldrup A 2003 Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic β-cells. Mol Endocrinol 17:945-958
45. Dheda K, Huggett J, Bustin SA, Johnson MA, Rook G, Zumla A 2004 Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques 37:112-119
46. Fleenor D, Arumugam R, Freemar M 2006 Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. Horm Res 66:101-110
47. Fleenor DE, Freemark M 2001 Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5. Endocrinology 142:2805-2810
48. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA 2000 Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 279:E1039-E1044
49. Kim JY, Koves TR, Yu GS, Gulick T, Cortright RN, Dohm GL, Muoio DM 2002 Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle. Am J Physiol Endocrinol Metab 282:E1014-E1022
50. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto AK, Goeke NM, Olson BJ, Klenk DC 1985 Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85
51. Antinozzi PA, Segall L, Prentki M, McGarry JD, Newgard CB 1998 Molecular or pharmacologic perturbation of the link between glucose and lipid metabolism is without effect on glucose-stimulated insulin secretion. A re-evaluation of the long-chain acyl-CoA hypothesis. J Biol Chem 273:16146-16154
52. Lindsay JR, Nieman LK 2005 The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 26:775-799
53. Kuhl C 1998 Etiology and pathogenesis of gestational diabetes. Diabetes Care 21(Suppl 2):B19-B26
54. Moldrup A, Petersen ED, Nielsen JH 1993 Effects of sex and pregnancy hormones on growth hormone and prolactin receptor gene expression in insulin-producing cells. Endocrinology 133:1165-1172
55. Fleenor D, Petryk A, Driscoll P, Freemark M 2000 Constitutive expression of placental lactogen in pancreatic β cells: effects on cell morphology, growth, and gene expression. Pediatr Res 47:136-142
56. Petryk A, Fleenor D, Driscoll P, Freemark M 2000 Prolactin induction of insulin gene expression: the roles of glucose and glucose transporter-2. J Endocrinol 164:277-286
57. Vasavada RC, Garcia-Ocana A, Zawalich WS, Sorenson RL, Dann P, Syed M, Ogren L, Talamantes F, Stewart AF 2000 Targeted expression of placental lactogen in the β cells of transgenic mice results in β cell proliferation, islet mass augmentation, and hypoglycemia. J Biol Chem 275:15399-15406
58. Parsons JA, Bartke A, Sorenson RL 1995 Number and size of islets of Langerhans in pregnant, human growth hormone-expressing transgenic, and pituitary dwarf mice: effect of lactogenic hormones. Endocrinology 136:2013-2021
59. Labriola L, Montor WR, Krogh K, Lojudice FH, Genzini T, Goldberg AC, Eliaschewitz FG, Sogayar MC 2007 Beneficial effects of prolactin and laminin on human pancreatic islet-cell cultures. Mol Cell Endocrinol 263:120-133
60. Fujinaka Y, Sipula D, Garcia-Ocana A, Vasavada RC 2004 Characterization of mice doubly transgenic for parathyroid hormone-related protein and murine placental lactogen: a novel role for placental lactogen in pancreatic β-cell survival. Diabetes 53:3120-3130
61. Fujinaka Y, Takane K, Yamashita H, Vasavada RC 2007 Lactogens promote β cell survival through JAK2/STAT5 activation and Bcl-XL upregulation. J Biol Chem 282:30707-30717
62. Holstad M, Sandler S 1999 Prolactin protects against diabetes induced by multiple low doses of streptozotocin in mice. J Endocrinol 163:229-234
63. Atwater I, Gondos B, DiBartolomeo R, Bazaes R, Jovanovic L 2002 Pregnancy hormones prevent diabetes and reduce lymphocytic infiltration of islets in the NOD mouse. Ann Clin Lab Sci 32:87-92
64. Jackerott M, Moldrup A, Thams P, Galsgaard ED, Knudsen J, Lee YC, Nielsen JH 2006 STAT5 activity in pancreatic β-cells influences the severity of diabetes in animal models of type 1 and 2 diabetes. Diabetes 55:2705-2712
65. Maccario M, Grottoli S, Razzore P, Procopio M, Oleandri SE, Ciccarelli E, Camanni F, Ghigo E 1996 Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity. Eur J Endocrinol 135:205-210
66. Foss MC, Paula FJ, Paccola GM, Piccinato CE 1995 Peripheral glucose metabolism in human hyperprolactinaemia. Clin Endocrinol (Oxf) 43:721-726
67. Freemark M, Avril I, Fleenor D, Driscoll P, Opara E, Kendall W, Oden J, Bridges S, Binart N, Breant B, Kelly PA 2002 Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. Endocrinology 143:1378-1385
68. Martinez SC, Cras-Meneur C, Bernal-Mizrachi E, Permutt MA 2006 Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet β-cell. Diabetes 55:1581-1591
69. Weinhaus AJ, Stout LE, Bhagroo NV, Brelje TC, Sorenson RL 2007 Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy. J Endocrinol 193:367-381
70. Hugl SR, Merger M 2007 Prolactin stimulates proliferation of the glucose-dependent β-cell line INS-1 via different IRS-proteins. JOP 8:739-752
71. Kim SJ, Winter K, Nian C, Tsuneoka M, Koda Y, McIntosh CH 2005 Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic β-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J Biol Chem 280:22297-22307
72. Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, Spiegelman BM 2003 Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1α interaction. Nature 423:550-555
73. Southgate RJ, Bruce CR, Carey AL, Steinberg GR, Walder K, Monks R, Watt MJ, Hawley JA, Birnbaum MJ, Febbraio MA 2005 PGC-1α gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle. FASEB J 19:2072-2074
74. Ravnskjaer K, Boergesen M, Dalgaard LT, Mandrup S 2006 Glucose-induced repression of PPARα gene expression in pancreatic β-cells involves PP2A activation and AMPK inactivation. J Mol Endocrinol 36:289-299
75. Nolan CJ, Madiraju MS, Delghingaro-Augusto V, Peyot ML, Prentki M 2006 Fatty acid signaling in the β-cell and insulin secretion. Diabetes 55(Suppl 2):S16-S23
76. Newsholme P, Keane D, Welters HJ, Morgan NG 2007 Life and death decisions of the pancreatic β-cell: the role of fatty acids. Clin Sci (Lond) 112:27-42
77. Wang X, Zhou L, Li G, Luo T, Gu Y, Qian L, Fu X, Li F, Li J, Luo M 2007 Palmitate activates AMP-activated protein kinase and regulates insulin secretion from β cells. Biochem Biophys Res Commun 352:463-468
78. Chan CB, Saleh MC, Koshkin V, Wheeler MB 2004 Uncoupling protein 2 and islet function. Diabetes 53(Suppl 1):S136-S142
79. Roduit R, Morin J, Masse F, Segall L, Roche E, Newgard CB, Assimacopoulos-Jeannet F, Prentki M 2000 Glucose down-regulates the expression of the peroxisome proliferator-activated receptor-α gene in the pancreatic β-cell. J Biol Chem 275:35799-35806
80. Guay C, Madiraju SR, Aumais A, Joly E, Prentki M 2007 A role for ATP-citrate lyase, malic enzyme, and pyruvate/citrate cycling in glucose-induced insulin secretion. J Biol Chem 282:35657-35665
81. Mulder H, Lu D, Finley J 4th, An J, Cohen J, Antinozzi PA, McGarry JD, Newgard CB 2001 Overexpression of a modified human malonyl-CoA decarboxylase blocks the glucose-induced increase in malonyl-CoA level but has no impact on insulin secretion in INS-1-derived (832/13) β-cells. J Biol Chem 276:6479-6484
82. Joseph JW, Odegaard ML, Ronnebaum SM, Burgess SC, Muehlbauer J, Sherry AD, Newgard CB 2007 Normal flux through ATP-citrate lyase or fatty acid synthase is not required for glucose-stimulated insulin secretion. J Biol Chem 282:31592-31600
83. Chakravarthy MV, Zhu Y, Lopez M, Yin L, Wozniak DF, Coleman T, Hu Z, Wolfgang M, Vidal-Puig A, Lane MD, Semenkovich CF 2007 Brain fatty acid synthase activates PPARα to maintain energy homeostasis. J Clin Invest 117:2539-2552
84. Karnik SK, Chen H, McLean GW, Heit JJ, Gu X, Zhang AY, Fontaine M, Yen MH, Kim SK 2007 Menin controls growth of pancreatic β-cells in pregnant mice and promotes gestational diabetes mellitus. Science 318:806-809
85. Cunha DA, Amaral ME, Carvalho CP, Collares-Buzato CB, Carneiro EM, Boschero AC 2006 Increased expression of SNARE proteins and synaptotagmin IV in islets from pregnant rats and in vitro prolactin-treated neonatal islets. Biol Res 39:555-566
86. Freemark M 1999 The fetal adrenal and the maturation of the growth hormone and prolactin axes. Endocrinology 140:1963-1965
87. Freemark M 2001 Ontogenesis of prolactin receptors in the human fetus: roles in fetal development. Biochem Soc Trans 29:38-41
88. Del Guerra S, Lupi R, Marselli L, Masini M, Bugliani M, Sbrana S, Torri S, Pollera M, Boggi U, Mosca F, Del Prato S, Marchetti P 2005 Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 54:727-735
89. Anello M, Lupi R, Spampinato D, Piro S, Masini M, Boggi U, Del Prato S, Abuazzo AM, Purrello F, Marchetti P 2005 Functional and morphological alterations of mitochondria in pancreatic β cells from type 2 diabetic patients. Diabetologia 48:282-289